AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex ...

ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex monogenic and polygenic diseases Generative AI ...

ElevateBio has entered into a multi-year collaboration with Amazon's cloud arm to identify treatment targets and new CRISPR systems.

The world received the first FDA-approved CRISPR therapy in December 2023. Image credit: Shutterstock / Panuwach. ElevateBio has partnered with Amazon Web Services (AWS) to expedite the discovery and ...

"As new studies continue to confirm the widespread presence of PFAS in water systems, consumer products, and environmental ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...

Last month, pharmaphorum spoke with Dr Charles C. Wykoff about the results from Apellis Pharmaceuticals’ OAKS study on intravitreal pegcetacoplan for geographic atrophy (GA), otherwise known as ...